Alyeska Investment Group, L.P.

Q4 2016 13F Holdings Report, New Holdings, Stock Holdings

Signature - Title
Jason Bragg - Chief Financial Officer
Location
Chicago, IL
Holdings as of
31 Dec 2016
Value $
$37,233,000
Num holdings
1
Filing time
20 Feb 2018, 16:58:51 UTC
Form type
13F-HR/A-4 - New Holdings
Description
Top holdings included BRCD. Request for Confidential Treatment (14 Feb 2017): Confidential Treatment Expired on 14 Feb 2018.
Previous filing
Q3 2016 - 14 Nov 2016
Next filing
Q1 2017 - 15 May 2017
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

This filing lists securities holdings reported on the form 13F filed on 14 Feb 2017 pursuant to a request for confidential treatment and for which confidential treatment expired on 14 Feb 2018.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Jason Bragg Chief Financial Officer Chicago, Illinois 20 Feb 2018

Other Included Managers (2):

Num Name Location File Number
1 Alyeska Master Fund, L.P. Chicago, IL 028-13417
2 Alyeska Master Fund 2, L.P. Chicago, IL 028-16151